10x Genomics (TXG) Other Working Capital Changes (2018 - 2026)

10x Genomics (TXG) has 9 years of Other Working Capital Changes data on file, last reported at -$50000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 91.3% year-over-year to -$50000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (down 138.84% YoY), and the FY2025 full-year result was -$1.8 million, down 325.9% from the prior year.
• Other Working Capital Changes eased to -$50000.0 in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $10.5 million in Q1 2023 to a low of -$8.3 million in Q2 2023.
• A 5-year average of $230176.5 and a median of $149000.0 in 2025 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes tumbled 2791.84% in 2024 and soared 4390.0% in 2025, its largest moves.
• Tracing TXG's Other Working Capital Changes over 5 years: stood at $6.5 million in 2022, then plunged by 143.03% to -$2.8 million in 2023, then jumped by 104.63% to $130000.0 in 2024, then soared by 4390.0% to $5.8 million in 2025, then slumped by 100.86% to -$50000.0 in 2026.
• Business Quant data shows TXG's Other Working Capital Changes at -$50000.0 in Q1 2026, $5.8 million in Q4 2025, and -$8.6 million in Q3 2025.